// App-Quantinova.ai

: Multiple ascending inhaled doses of AZD8871 in healthy males

Researchers

Presenter

  • Victor Balaguer Sole

Principal Investigators

  • Muna Albayaty

  • Carol Astbury

  • Lali Jimenez

  • Ulrika Wahlby Hamren

  • Beatriz Seoane

  • Marie-Pierre Malice

  • Alejhandra Lei

  • Ajay Aggarwal

  • Ioannis Psallidas

Medical Centers

  • RIA TMU, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Barcelona, Spain,

  • PAREXEL International GmbH, London, United Kingdom

  • Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, AstraZeneca, Barcelona, Spain.

  • Quantitative Clinical Pharmacology, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Waltham, MA, United States,

  • Quantitative Clinical Pharmacology, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Waltham, MA, United States,

  • Biometrics and Information Sciences, Research & Development, GMD, AstraZeneca, Barcelona, Spain

  • RIA TMU, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Barcelona, Spain,

  • Patient Safety RIA, GRAPSQA, GMD Development, AstraZeneca, Barcelona, Spain,

  • RIA TMU, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Boston, MA, United States.

  • Early Clinical Development, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden

Locations

  • Spain

  • United Kingdom

  • Sweden

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

Phase

  • I

Study Id's

  • NCT02814656

  • NCT03159442

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved